We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Skin & Soft Tissue Focus Group

The ESTRO Skin and Soft Tissue Focus Group is an interdisciplinary team comprised of Radiation and Clinical Oncologists, Medical Physicists, and Radiation Therapists with a specific interest in the management of skin and soft tissue neoplasms.

Given the variation in clinical practice, the Focus Group aims to harmonise radiation therapy practice and disseminate knowledge by standardising radiation therapy planning and delivery techniques. Rare cancers are common in both tumour sub-types and can be challenging to treat. This ESTRO Skin and Soft Tissue Focus Group will outline the principles of treatment and the optimal treatment schedules in instances where the evidence base is limited.

Cancer treatment is multi-faceted, and this ESTRO Focus Group will engage with other ESTRO Committees, as well as partners in biotechnology, pharma, surgery, dermatology, and medical oncology, to foster closer relationships across these disciplines. The Group serves as an expert resource and advice to ESTRO Councils and Committees, and is open to collaborative activities, advocacy, and engagement with internal and external stakeholders.

  • Education: Evidence-based guidelines in Skin Cancer and Soft Tissue Sarcoma. Multi-professional educational events.
     
  • Technology: Patient specific 3D printing in Skin Cancer and Soft Tissue Sarcoma. Brachytherapy. Radiation Therapist led pathway.
     
  • Research / Translational work: Harmonise research endpoints. Biologics and radiosensitivity of Skin / Skin Cancer and Soft Tissue Sarcoma. Combination therapy.
     
  • Health related quality of life: Functional and cosmetic outcomes following treatment for Skin Cancer. Radiodermatitis.
     
  • Rare cancers: Merkel cell carcinoma, pleomorphic dermal sarcoma, angiosarcoma, Kaposi sarcoma, porocarcinoma.
     
  • Radiotherapy in benign conditions: keloids, skin pre-cancer diagnoses

Co-Chair - Skin Cancer:

Agata Rembielak, Radiation Oncologist, The Christie, Manchester Academic Health Science Centre (UK)

Co-Chair - Soft Tissue Sarcoma:

Beate Timmermann, Radiation Oncologist, West German Proton Therapy Center Essen  (DE)

Secretary and Core Expert - Skin Cancer:

Romaana Mir, Clinical Oncologist, Mount Vernon Cancer Centre (UK)

Core Expert - Soft Tissue Sarcoma:

Rick Haas, Radiation Oncologist,  Netherlands Cancer Institute (NL) and the Leiden University Medical Center (NL)

Core Expert - Skin Cancer:

Nikolaos Tselis, Radiation Oncologist, Goethe University Frankfurt  (DE)

Full Members:

Shane Zaidi, Clinical Oncologist, The Royal Marsden, NHS Foundation Trust  (UK)

Marta Szlag, Medical Physicist, Maria Sklodowska-Curie National Research Institute of Oncology  Gliwice branch  (PL)

Line Claude, Radiation Oncologist, Centre Léon Bérard (FR)

Patrizia Cornacchione, RTT, Fondazione Policlinico Universitario A. Gemelli IRCCS (IT)

Siyer Roohani, Radiation Oncologist, Charité Universitätsmedizin Berlin (DE)

Catherine Wilson, RTT, The James Cook University hospital Middlesbrough  (UK)

Elizabeth Barnes, Radiation Oncologist, Odette Cancer Centre (CA)

Bruno Fionda, Radiation Oncologist, Fondazione Policlinico Universitario Agostino gemelli IRCCS (IT)

Vassilis Kouloulias, Radiation Oncologist, National Kapodistrian University of Athens, Attikon Hospital  (GR)

Vassilios Vassiliou, Radiation Oncologist, Bank of Cyprus Oncology Centre (CY)

Renate Walter, Medical Physicist, University Hospital Augsburg  (DE)

Melissa Christiaens, Radiation Oncologist, University Hospitals Leuven (BE)

Marcin Miszczyk, Radiation Oncologist, Medical University of Vienna (AT)

Mateusz Spałek, Radiation Oncologist, Maria Sklodowska-Curie National Research Institute of Oncology (PL)

Brendan McCann, Clinical Oncologist,  Beatson West of Scotland Cancer Centre  (UK)

Franziska Eckert, Biologist/Radiation Oncologist, Medical University Vienna (AT)

More information coming soon.